Gregory Shaw Garfield
Gregory Shaw Garfield occupies the position of Senior Managing Director at KCK Group LLC. Mr. Garfield is also Senior Managing Director at Kck Us, Inc. and on the board of 12 other companies.
In his past career Mr. Garfield occupied the position of Vice President-New Business Development at Boston Scientific Corp. and VP & General Counsel-Cardiac Surgery Group at Guidant Corp. (a subsidiary of Boston Scientific Corp.), Chief Operating Officer & General Counsel at Acclarent, Inc. and Attorney at Pillsbury Winthrop LLP.
Mr. Garfield received an undergraduate degree from California Polytechnic State University (San Luis Obispo) and a graduate degree from Mcgeorge School of Law.
Transactions
Date
Transaction
Value
| 04/26/2021 | 5,595,493 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/26/2021 | 18,891 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/26/2021 | 5,595,493 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/21/2021 | 13,235 | Acquisition at $17 per share. | 224,995 |
